Use of the French Healthcare Insurance Database
NCT02983968 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75868
Last updated 2026-06-12
Summary
Hepatocellular carcinoma (HCC) has become the second most common cause of cancer death in the world, estimated responsible for nearly 745,000 deaths in 2012 (9.1% of all cancer deaths).
Conditions
Interventions
- OTHER
-
Description of the cirrhosis management
Sponsors & Collaborators
-
Centre Hospitalier Universitaire, Amiens
lead OTHER
Principal Investigators
-
Olivier GANRY, MD, PhD · CHU Amiens
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-07
- Primary Completion
- 2019-04-09
- Completion
- 2019-04-09
Countries
- France
Study Locations
More Related Trials
-
National Cohort of Uncomplicated Alcoholic Cirrhosis
NCT01213927 ·Status: UNKNOWN
-
CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
NCT05623150 ·Status: RECRUITING
-
Hepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver Disease
NCT03307408 ·Status: COMPLETED
-
FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.
NCT05095714 ·Status: RECRUITING ·Phase: NA
-
Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and Recommendations
NCT04189809 ·Status: UNKNOWN
-
Coffee Consumption and NASH in the French Population.
NCT03432377 ·Status: COMPLETED
-
Identification, Molecular Epidemiology Angiosarcoma of the Liver France
NCT01786889 ·Status: UNKNOWN ·Phase: NA
-
Prevalence of Liver Fibrosis and Cirrhosis in Patients With Squamous Cell Carcinoma of the Head and Neck
NCT03139058 ·Status: TERMINATED ·Phase: NA
-
Study of Hemodynamic Conditions Measured During Hepatectomy
NCT03371537 ·Status: COMPLETED
-
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
NCT03894917 ·Status: RECRUITING
-
LIVER FIBROSIS PREVALENCE IN FRANCE
NCT01927133 ·Status: UNKNOWN
-
Phenotyping Liver Cancer Registry
NCT04681274 ·Status: COMPLETED
-
Cohort Study of Patients With Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of Chemoembolization
NCT05390112 ·Status: UNKNOWN
-
City-Hospital Collaboration for Early Detection of Liver Fibrosis in Primary Care: A Secondary Prevention Project in the Grenoble Health Area
NCT07031089 ·Status: RECRUITING
-
Identification of Image Phenotypes to Predict Recurrence After Resection of Hepatocellular Carcinoma
NCT05235490 ·Status: COMPLETED
-
Impact of IL-28B rs12979860 and rs4803217 Gene Polymorphisms Associated With miRNAs Deregulation on HCV-related Hepatocellular Carcinoma
NCT02507882 ·Status: UNKNOWN ·Phase: NA
-
Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients
NCT04802954 ·Status: COMPLETED ·Phase: NA
-
Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease
NCT04106518 ·Status: RECRUITING
-
NASH and Coronary Disease
NCT03819283 ·Status: UNKNOWN ·Phase: NA
-
Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients
NCT01798173 ·Status: COMPLETED ·Phase: NA
-
Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis
NCT06160271 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment
NCT01492127 ·Status: UNKNOWN ·Phase: NA
-
Liver Diseases: Extracellular Vesicles as Biomarkers
NCT07185360 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A National Registry of Patients With Hepatocellular Carcinoma
NCT00178867 ·Status: COMPLETED
-
Study to Evaluate a High Intensity Focused Ultrasound (HIFU) Procedure in Patient With Liver Metastases
NCT01489787 ·Status: UNKNOWN ·Phase: NA